Results 21 to 30 of about 1,681,482 (253)
Saliva: Newer avenues in the era of molecular biology, diagnostic and prognostic application
Journal of Medical Sciences, 2018 The salivary fluid has an old history of study, but its physiological importance has only been recognized recently. In the past 50 years, the pace of salivary research has accelerated with the advent of new techniques that illuminated the biochemical and physicochemical properties of saliva.
Abhishek Singh Nayyar +6 more
openaire +2 more sources
American Journal of Transplantation, 2020 We conducted this study using the updated 2005-2016 Organ Procurement and Transplantation Network database to assess clinical outcomes of retransplant after allograft loss as a result of BK virus-associated nephropathy (BKVAN). Three hundred forty-one patients had first graft failure as a result of BKVAN, whereas 13 260 had first graft failure as a ...
Napat Leeaphorn +5 more
openaire +2 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT As part of the European Cooperative Study Group for Paediatric Rare Tumours initiative, we developed standard clinical practice guidelines for ovarian sex cord stromal tumors, based on comprehensive national and international cohort analyses, literature review, and a final expert consensus conference.
Dominik T. Schneider +15 more
wiley +1 more source
OncoTargets and Therapy, 2011 The incidence of melanoma is rising. The primary initial treatment for melanoma continues to be wide local excision of the primary tumor and affected lymph nodes. Exceptions to wide local excision include cases where surgical excision may be cosmetically disfiguring or associated with increased morbidity and mortality.
Khan,Mohammad K +3 more
openaire +4 more sources
Impact of Chronic Kidney Disease on Clinical Outcomes in Diabetic Patients Undergoing Percutaneous Coronary Intervention in the Era of Newer-Generation Drug-Eluting Stents [PDF]
Korean Circulation Journal, 2017 Chronic kidney disease (CKD) is known to be a major adverse predictor in diabetes mellitus (DM) patients undergoing percutaneous coronary intervention (PCI). It is expected that the use of newer-generation drug-eluting stents (DES) would improve clinical outcomes in these patients.
Kim, Su-Min +12 more
openaire +2 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Adolescents with high‐risk cancer face complex developmental, psychosocial, and ethical challenges that extend beyond disease‐directed treatment. Although international recommendations exist for communication, psychosocial care, pediatric palliative care, survivorship, and shared decision‐making, these have largely evolved within ...
Johanna M. C. Blom +15 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani +7 more
wiley +1 more source
Newer Determinants of an Old Problem: Factors for Suicidal Behaviour in the Current Era
, 2022 BACKGROUND: The national record crime bureau of India reported more than 1.53 lakh suicide in 2020, which is the highest in the last decade. Suicide can be considered a public health problem. Suicide risk assessment is complex, having contributions from biopsychosocial and environmental influences.
Mohapatra, Satyakam +2 more
openaire +1 more source
The biochemical-mode of action of some newer azole fungicides
, 1993 The effects of the newer azole fungicides BAS 480F, flusilazole, and tebuconazole on growth and sterol composition of the plant pathogenic fungi Botrytis cinerea, Pyrenophora teres, Pyricularia oryzae, Rhynchosporium secalis, Ustilago maydis and Erysiphe
R. Thomas Loeffler +3 more
core +1 more source
Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin +17 more
wiley +1 more source